QualityStocks

[QualityStocks]

QualityStocksNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Expands Wellness and Relief Portfolio with PLUS CBDRelief 1:1 Pomegranate

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis and hemp branded products company in the U.S., today announced the expansion of its recently launched wellness and relief brand, PLUS CBDRelief, with the introduction of a new Pomegranate 1:1 CBD to THC ratio product. According to the update, the new PLUS CBDRelief 1:1 Pomegranate gummy, with 5mg of THC and 5mg of CBD per serving, is made with real California pomegranates containing ellagitannins, unique antioxidants found in pomegranates that are associated with anti-inflammatory pathways.* “Last year we partnered with market structure research firm, HJ Rak & Associates, and found that when consumers used cannabis, over one-third of the time it was to address pain, stress or anxiety,” Jake Heimark, co-founder and CEO of Plus Products, stated in the news release. “We sought to satisfy this consumer need state by launching the PLUS CBDRelief line, which 80% of our California retail distribution network has picked up since its launch earlier this year. After what we believe was a successful rollout, we are excited to expand our wellness and relief portfolio with this new product introduction.”

To view the full press release, visit http://ibn.fm/ibBa9

About PLUS
PLUS is a hemp and cannabis food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable – that begins with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, CA. For more information, visit the Company’s website at www.PlusProducts.com.

*M Ghavipour, G Sotoudeh, E Tavakoli, K Mowla, J Hasanzadeh & Z Mazloom. 2016. Pomegranate extract alleviates disease activity and some blood biomarkers of inflammation and oxidative stress in Rheumatoid Arthritis patients. European Journal of Clinical Nutrition. Accessed June 24, 2020. Volume (71). https://www.nature.com/articles/ejcn2016151

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF